RxDoctor Payments Data

Darla Cowart, MD

Family Medicine · Huntsville, ALNPI 1114988698

Payments from drug & device makers

$1,732in general payments, 2019–2025

Across 97 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$315
  • Pfizer$293
  • Biohaven Pharmaceutical Holding Company Ltd.$146
  • Sanofi Pasteur Inc.$146
  • Novo Nordisk$133
  • Abbott$112
  • plus $588 from 17 others

What the payments were for

  • Food & beverage$1,732100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,732 in reported general payments places this provider in the 65th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$95,245
Medicare patients
180
Services billed
1,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$49,338
MounjaroTirzepatide27$26,946
EliquisApixaban22$26,684
JardianceEmpagliflozin23$21,941
Levothyroxine Sodium164$2,900
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,470
Tolterodine Tartrate ErTolterodine Tartrate14$2,236
Estradiol23$2,094
Atorvastatin Calcium124$2,029
SynthroidLevothyroxine Sodium23$1,819
Rosuvastatin Calcium87$1,709
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl11$1,692
Omeprazole147$1,674
Liothyronine Sodium18$1,496
Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide25$1,342

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$133$49,33839 claims
Lilly USA, LLCMounjaro$315$26,94627 claims
PfizerEliquis$293$26,68422 claims
Boehringer IngelheimJardiance$107$21,94123 claims
AbbVieSynthroid$70$1,81923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →